Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia.
Saved in:
| Title: | Author Correction: Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia. |
|---|---|
| Authors: | Bassal MA; Harvard Stem Cell Institute, Harvard Medical School, Boston, USA.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Samaraweera SE; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Lim K; Discipline of Medicine, University of Adelaide, Adelaide, Australia., Benard BA; Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Stanford, USA., Bailey S; Clinical and Health Sciences, University of South Australia, Adelaide, Australia., Kaur S; Discipline of Medicine, University of Adelaide, Adelaide, Australia., Leo P; Diamantina Institute, Translational Research Institute, Brisbane, Australia., Toubia J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Thompson-Peach C; Discipline of Medicine, University of Adelaide, Adelaide, Australia., Nguyen T; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Maung KZY; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Casolari DA; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Iarossi DG; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Pagani IS; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia., Powell J; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Pitson S; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Natera S; Metabolomics Australia, The University of Melbourne, Melbourne, Australia., Roessner U; Metabolomics Australia, The University of Melbourne, Melbourne, Australia., Lewis ID; Adelaide Oncology & Haematology, Adelaide, Australia., Brown AL; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.; Clinical and Health Sciences, University of South Australia, Adelaide, Australia.; Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, SA, Australia., Tenen DG; Harvard Stem Cell Institute, Harvard Medical School, Boston, USA.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Robinson N; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia., Ross DM; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.; Discipline of Medicine, University of Adelaide, Adelaide, Australia.; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia.; Department of Clinical Haematology, Royal Adelaide Hospital, Adelaide, Australia., Majeti R; Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Stanford, USA., Gonda TJ; Clinical and Health Sciences, University of South Australia, Adelaide, Australia.; School of Pharmacy, University of Queensland, Brisbane, Australia., Thomas D; Discipline of Medicine, University of Adelaide, Adelaide, Australia.; Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Stanford, USA.; Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia., D'Andrea RJ; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia. Richard.DAndrea@unisa.edu.au. |
| Source: | Nature communications [Nat Commun] 2022 Jul 15; Vol. 13 (1), pp. 4131. Date of Electronic Publication: 2022 Jul 15. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-31952-7 |
